GLOBUS MEDICAL, INC. (GMED) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | Gross Profit |
| Revenue | 3.14B USD | |
| Cost of products and services | 989.14M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $3.14B | $989.14M | (m) |
| 2026-03-31 | (m) | $3.10B | $996.47M | (m) |
| 2025-12-31 | (m) | $2.94B | $957.80M | (m) |
| 2025-09-30 | (m) | $2.77B | $960.13M | (m) |
| 2025-06-30 | (m) | $2.63B | $978.11M | (m) |
| 2025-03-31 | (m) | $2.51B | $989.39M | (m) |
| 2024-12-31 | (m) | $2.52B | $1.04B | (m) |
| 2024-09-30 | (m) | $2.48B | $1.04B | (m) |
| 2024-06-30 | $1.33B | $2.24B | $902.40M | 59.65% |
| 2024-03-31 | $1.18B | $1.90B | $718.84M | 62.14% |
| 2023-12-31 | $1.02B | $1.57B | $548.17M | 65.05% |
| 2023-09-30 | $873.16M | $1.23B | $353.28M | 71.19% |
| 2023-06-30 | $813.56M | $1.10B | $283.39M | 74.17% |
| 2023-03-31 | $793.60M | $1.07B | $275.38M | 74.24% |
| 2022-12-31 | $759.12M | $1.02B | $263.73M | 74.22% |
| 2022-09-30 | $743.44M | $998.37M | $254.93M | 74.47% |
| 2022-06-30 | $725.95M | $973.94M | $247.99M | 74.54% |
| 2022-03-31 | $717.94M | $961.31M | $243.36M | 74.68% |
| 2021-12-31 | $718.88M | $958.10M | $239.22M | 75.03% |
| 2021-09-30 | $703.24M | $941.53M | $238.29M | 74.69% |
| 2021-06-30 | $691.07M | $927.90M | $236.83M | 74.48% |
| 2021-03-31 | $602.18M | $825.81M | $223.63M | 72.92% |
| 2020-12-31 | $571.58M | $789.04M | $217.46M | 72.44% |
| 2020-09-30 | $561.90M | $767.26M | $205.37M | 73.23% |
| 2020-06-30 | $553.73M | $747.38M | $193.65M | 74.09% |
| 2020-03-31 | $606.00M | $793.00M | $187.00M | 76.42% |
| 2019-12-31 | $605.39M | $785.37M | $179.97M | 77.08% |
| 2019-09-30 | $592.47M | $769.64M | $177.17M | 76.98% |
| 2019-06-30 | $573.03M | $742.66M | $169.63M | 77.16% |
| 2019-03-31 | $558.23M | $721.50M | $163.28M | 77.37% |
| 2018-12-31 | $553.56M | $712.97M | $159.41M | 77.64% |
| 2018-09-30 | $538.75M | $693.07M | (m) | 77.73% |
| 2018-06-30 | $522.31M | $675.57M | (m) | 77.31% |
| 2018-03-31 | $501.76M | $654.58M | (m) | 76.65% |
| 2017-12-31 | $485.52M | $635.98M | (m) | 76.34% |
| 2017-09-30 | $462.93M | $611.53M | (m) | 75.70% |
| 2017-06-30 | $452.19M | $595.44M | (m) | 75.94% |
| 2017-03-31 | $441.75M | $580.54M | (m) | 76.09% |
| 2016-12-31 | $429.29M | $563.99M | (m) | 76.12% |
| 2016-09-30 | $423.88M | $554.99M | (m) | 76.38% |
| 2016-06-30 | $423.71M | $556.33M | (m) | 76.16% |
| 2016-03-31 | $420.07M | $552.41M | (m) | 76.04% |
| 2015-12-31 | $411.95M | $544.75M | (m) | 75.62% |
| 2015-09-30 | $401.95M | $530.97M | (m) | 75.70% |
| 2015-06-30 | $388.11M | $511.76M | (m) | 75.84% |
| 2015-03-31 | $374.11M | $491.76M | (m) | 76.08% |
| 2014-12-31 | $363.51M | $474.37M | (m) | 76.63% |
| 2014-09-30 | $354.46M | $460.81M | (m) | 76.92% |
| 2014-06-30 | $346.23M | $450.21M | (m) | 76.90% |
| 2014-03-31 | $341.49M | $443.65M | (m) | 76.97% |
| 2013-12-31 | $334.12M | $434.46M | (m) | 76.90% |
| 2013-09-30 | $326.62M | $419.75M | (m) | 77.81% |
| 2013-06-30 | $320.64M | $407.33M | (m) | 78.72% |
| 2013-03-31 | $315.99M | $396.30M | (m) | 79.74% |
| 2012-12-31 | $310.80M | $385.99M | (m) | 80.52% |
| 2012-09-30 | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) |
| 2012-03-31 | $275.63M | $347.92M | (m) | 79.22% |
| 2011-12-31 | $262.68M | $331.48M | (m) | 79.25% |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | $234.37M | $288.19M | (m) | 81.32% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |